Ketamine and Psychedelic Substances in Practice: What Providers and Communities Need to Know

LIVE WEBINAR | APRIL 16, 2026
Register NowThis advanced session explores the evolving landscape of ketamine and other psychedelic substances as they appear in clinical settings, community conversations, and personal use. Participants will examine current evidence, emerging models of care, ethical considerations, and how providers can engage in informed, nonjudgmental conversations while navigating Maryland’s legal and clinical context.
Learning Objectives
After completing this activity, the participant should be better able to:
- Summarize the current legal status, regulatory considerations, and ethical risks related to psychedelic substances in the United States, with attention to clinical practice implications in Maryland.
- Explore core components of psychedelic-assisted therapy and psychedelic harm-reduction models, including preparation, navigation, and integration practices relevant to outpatient mental health settings.
- Apply clinical screening principles to identify appropriate and inappropriate candidates for psychedelic-related work, including recognizing contraindications, special population considerations, and referral pathways for safe client care.
Faculty
Lauren C. Going t, LCSW-C, RYT is a Maryland based psychotherapist and co-founder of Inner Path Wellness, the city’s first psychedelic-assisted therapy center. She specializes in ketamine- and psychedelic-assisted therapies and provides training and consultation on trauma-informed and integrative care approaches. Ms. Going also serves as an integration therapist for research studies at Johns Hopkins and Sheppard Pratt and is an experienced speaker and educator in emerging therapeutic practices.